These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 39119004)
1. Assessing the impact of short-term Lugol's solution on toxic nodular thyroid disease: a pre-post-intervention study. Hedberg F; Cramon PK; Bränström R; Falhammar H; Calissendorff J Front Endocrinol (Lausanne); 2024; 15():1420154. PubMed ID: 39119004 [TBL] [Abstract][Full Text] [Related]
2. High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. Amato G; Mazziotti G; Sorvillo F; Piscopo M; Lalli E; Biondi B; Iorio S; Molinari A; Giustina A; Carella C Bone; 2004 Sep; 35(3):785-91. PubMed ID: 15336617 [TBL] [Abstract][Full Text] [Related]
3. Quality-of-Life Impairments Persist Six Months After Treatment of Graves' Hyperthyroidism and Toxic Nodular Goiter: A Prospective Cohort Study. Cramon P; Winther KH; Watt T; Bonnema SJ; Bjorner JB; Ekholm O; Groenvold M; Hegedüs L; Feldt-Rasmussen U; Rasmussen ÅK Thyroid; 2016 Aug; 26(8):1010-8. PubMed ID: 27370744 [TBL] [Abstract][Full Text] [Related]
4. Lugol's solution-induced painless thyroiditis. Yang JW; How J Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28620500 [TBL] [Abstract][Full Text] [Related]
5. Rescue pre-operative treatment with Lugol's solution in uncontrolled Graves' disease. Calissendorff J; Falhammar H Endocr Connect; 2017 May; 6(4):200-205. PubMed ID: 28325735 [TBL] [Abstract][Full Text] [Related]
6. Rapid preoperative blockage of thyroid hormone production / secretion in patients with Graves' disease. Fischli S; Lucchini B; Müller W; Slahor L; Henzen C Swiss Med Wkly; 2016; 146():w14243. PubMed ID: 26765838 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre. Rieu M; Bekka S; Sambor B; Berrod JL; Fombeur JP Clin Endocrinol (Oxf); 1993 Jul; 39(1):67-71. PubMed ID: 8348708 [TBL] [Abstract][Full Text] [Related]
8. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency. Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614 [TBL] [Abstract][Full Text] [Related]
9. [Autonomy of the thyroid gland: is there an "organ hyperthyroidism" of "euthyroid" patients?]. Wawrzyn H; Hesch RD Med Klin (Munich); 2000 Aug; 95(8):421-8. PubMed ID: 10985062 [TBL] [Abstract][Full Text] [Related]
10. The effect of preoperative Lugol's iodine on intraoperative bleeding in patients with hyperthyroidism. Yilmaz Y; Kamer KE; Ureyen O; Sari E; Acar T; Karahalli O Ann Med Surg (Lond); 2016 Aug; 9():53-7. PubMed ID: 27408715 [TBL] [Abstract][Full Text] [Related]
11. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism. Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745 [TBL] [Abstract][Full Text] [Related]
12. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease. De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104 [TBL] [Abstract][Full Text] [Related]
13. Effect of Lugol's solution on Chai J; Zhang R; Zheng W; Zhang G; Jia Q; Tan J; Meng Z; Wang R Clin Exp Med; 2023 Jul; 23(3):825-831. PubMed ID: 35840869 [TBL] [Abstract][Full Text] [Related]
14. Five-year follow-up of percutaneous ethanol injection for the treatment of hyperfunctioning thyroid nodules: a study of 117 patients. Monzani F; Caraccio N; Goletti O; Lippolis PV; Casolaro A; Del Guerra P; Cavina E; Miccoli P Clin Endocrinol (Oxf); 1997 Jan; 46(1):9-15. PubMed ID: 9059552 [TBL] [Abstract][Full Text] [Related]
16. Improved quality of life in hyperthyroidism patients after surgery. Bukvic B; Zivaljevic V; Sipetic S; Diklic A; Tausanovic K; Stojanovic D; Stevanovic D; Paunovic I J Surg Res; 2015 Feb; 193(2):724-30. PubMed ID: 25167783 [TBL] [Abstract][Full Text] [Related]
17. Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs. Koornstra JJ; Kerstens MN; Hoving J; Visscher KJ; Schade JH; Gort HB; Leemhuis MP Neth J Med; 1999 Nov; 55(5):215-21. PubMed ID: 10593131 [TBL] [Abstract][Full Text] [Related]
18. [Effect of preoperative administration of Lugol's solution on thyroid blood flow in hyperthyroidism]. Rodier JF; Janser JC; Petit H; Schneegans O; Ott G; Kaissling A; Grob JC; Velten M Ann Chir; 1998; 52(3):229-33. PubMed ID: 9752450 [TBL] [Abstract][Full Text] [Related]
19. Effect of Lugol's iodine on the vascularity of thyroid gland in hyperthyroidism. Rangaswamy M; Padhy AK; Gopinath PG; Shukla NK; Gupta K; Kapoor MM Nucl Med Commun; 1989 Sep; 10(9):679-84. PubMed ID: 2616107 [TBL] [Abstract][Full Text] [Related]
20. Lugol's iodine: its effect on thyroid blood flow in patients with thyrotoxicosis. Marigold JH; Morgan AK; Earle DJ; Young AE; Croft DN Br J Surg; 1985 Jan; 72(1):45-7. PubMed ID: 3967130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]